Vanguard Group Inc Codex Dna, Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DNAY
# of Institutions
23Shares Held
10.8MCall Options Held
0Put Options Held
0-
Northpond Ventures, LLC9.84MShares$18.2 Million51.1% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny232KShares$429,9300.0% of portfolio
-
Geode Capital Management, LLC Boston, MA83.6KShares$154,5870.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX67KShares$123,9500.0% of portfolio
-
Vontobel Holding Ltd.50KShares$92,5000.0% of portfolio
About Codex DNA, Inc.
- Ticker DNAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 29,518,200
- Market Cap $54.6M
- Description
- Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...